These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


77 related items for PubMed ID: 8906854

  • 1. Prevention of autoimmune diabetes by linomide in nonobese diabetic (NOD) mice is associated with up-regulation of the TCR-mediated activation of p21(ras).
    Rapoport MJ, Weiss L, Mor A, Bistritzer T, Ramot Y, Slavin S.
    J Immunol; 1996 Nov 15; 157(10):4721-5. PubMed ID: 8906854
    [Abstract] [Full Text] [Related]

  • 2. Ras inhibition increases the frequency and function of regulatory T cells and attenuates type-1 diabetes in non-obese diabetic mice.
    Mor A, Kloog Y, Keren G, George J.
    Eur J Pharmacol; 2009 Aug 15; 616(1-3):301-5. PubMed ID: 19527709
    [Abstract] [Full Text] [Related]

  • 3. Prevention and treatment of type I diabetes in NOD mice by linomide.
    Slavin S, Gross D, Weiss L.
    Transplant Proc; 1995 Dec 15; 27(6):3240. PubMed ID: 8539933
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prevention of diabetes mellitus in non-obese diabetic mice by Linomide, a novel immunomodulating drug.
    Gross DJ, Sidi H, Weiss L, Kalland T, Rosenmann E, Slavin S.
    Diabetologia; 1994 Dec 15; 37(12):1195-201. PubMed ID: 7895948
    [Abstract] [Full Text] [Related]

  • 10. Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy.
    Qin HY, Elliott JF, Lakey JR, Rajotte RV, Singh B.
    J Autoimmun; 1998 Dec 15; 11(6):591-601. PubMed ID: 9878081
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Preventive and therapeutic potential of p38 alpha-selective mitogen-activated protein kinase inhibitor in nonobese diabetic mice with type 1 diabetes.
    Medicherla S, Protter AA, Ma JY, Mangadu R, Almirez R, Koppelman B, Kerr I, Navas TA, Movius F, Reddy M, Liu YW, Luedtke G, Perumattam J, Mavunkel B, Dugar S, Schreiner GF.
    J Pharmacol Exp Ther; 2006 Jul 15; 318(1):99-107. PubMed ID: 16603672
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Acceleration of spontaneous diabetes in TCR-beta-transgenic nonobese diabetic mice by beta-cell cytotoxic CD8+ T cells expressing identical endogenous TCR-alpha chains.
    Verdaguer J, Yoon JW, Anderson B, Averill N, Utsugi T, Park BJ, Santamaria P.
    J Immunol; 1996 Nov 15; 157(10):4726-35. PubMed ID: 8906855
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.